Aducanumab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Aducanumab, covering 2017-01-13 to 2023-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4) [Phase 3]